Biogend Therapeutics Co Ltd banner

DCF Value

The DCF Value for Biogend Therapeutics Co Ltd (6733) under the Base Case is -8.54 TWD. Compared with the current market price of 24.4 TWD, the stock appears Overvalued by 100% .

Key assumptions
DCF Value
Base Case
NT$-8.54
Overvaluation 100%
DCF Value
Price NT$24.4
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time